Louise Nott

645 citations
10 papers · 132 indexed · h-index 6
Topics
Advanced Breast Cancer Therapies (3 papers)HER2/EGFR in Cancer Research (3 papers)Gastric Cancer Management and Outcomes (2 papers)
Partner nations
AustraliaCanadaSlovakia

In The Last Decade

Louise Nott

10 papers receiving 128 citations

Peers

Louise Nott
Comparison fields: 5 of 41
  • Oncology 48
  • Pulmonary and Respiratory Medicine 38
  • Clinical Biochemistry 34
  • Pediatrics, Perinatology and Child Health 30
  • Molecular Biology 17
Replace Paul Parker with:
Paul Parker United States
M R Narkewicz United States
Carin A.T.C. Lunenburg Netherlands
Lilla Lakner Hungary
Patricia Bastick Australia
Zoraida Corte Spain
Janine Bullard United States
Yeon-Kyeong Yoo South Korea
Shripad Chitnis United States
Anne-Sophie Dieudonné Belgium
Louise Nott relative to Paul Parker United States Paul Parker's profile →
Citations per field
00.5×5.3×
Paul Parker · 1×
Citations per year

Countries citing papers authored by Louise Nott

Since Specialization
Citations

This map shows the geographic impact of Louise Nott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Nott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Nott more than expected).

Fields of papers citing papers by Louise Nott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Nott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Nott. The network helps show where Louise Nott may publish in the future.

Co-authorship network of co-authors of Louise Nott

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Nott. A scholar is included among the top collaborators of Louise Nott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Nott. Louise Nott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 7
2 7
3 1
4 1
5 1
6 5
7 10
8 3
9 14
10 83

About Louise Nott

Louise Nott is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 10 papers that have together received 132 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Clinical Biochemistry (34 citations), Oncology (48 citations) and Pediatrics, Perinatology and Child Health (30 citations). Louise Nott has collaborated with scholars based in Australia, Canada and Slovakia. Frequent co-authors include Ken Pittman, Janice Fletcher, Timothy Price, Mark Shackleton, Belinda E. Kiely, Stephen Clarke, Geoffrey Liu, Richard de Boer, Sanjeev Gill and Matthew Burge. Their work appears in journals such as Cancer Research, The Oncologist and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026